Personal Capital Advisors Corp increased its holdings in Colgate-Palmolive (NYSE:CL) by 10.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 486,980 shares of the company’s stock after acquiring an additional 47,506 shares during the quarter. Personal Capital Advisors Corp owned about 0.06% of Colgate-Palmolive worth $34,907,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also made changes to their positions in CL. Virtue Capital Management LLC purchased a new stake in Colgate-Palmolive in the fourth quarter worth $104,000. Centerpoint Advisors LLC purchased a new position in Colgate-Palmolive during the first quarter valued at $112,000. Princeton Capital Management LLC purchased a new position in Colgate-Palmolive during the first quarter valued at $117,000. Calton & Associates Inc. purchased a new position in Colgate-Palmolive during the fourth quarter valued at $126,000. Finally, Cerebellum GP LLC purchased a new position in Colgate-Palmolive during the fourth quarter valued at $129,000. 73.30% of the stock is owned by institutional investors.
Get Colgate-Palmolive alerts:
In related news, Director Helene D. Gayle sold 7,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, May 10th. The stock was sold at an average price of $62.23, for a total value of $435,610.00. Following the completion of the sale, the director now directly owns 35,395 shares in the company, valued at approximately $2,202,630.85. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Daniel B. Marsili sold 5,692 shares of Colgate-Palmolive stock in a transaction dated Wednesday, February 21st. The stock was sold at an average price of $70.19, for a total value of $399,521.48. Following the completion of the sale, the insider now owns 41,677 shares of the company’s stock, valued at $2,925,308.63. The disclosure for this sale can be found here. Insiders have sold 147,771 shares of company stock valued at $9,381,205 over the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Several brokerages have commented on CL. Citigroup raised their price objective on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. Barclays set a $75.00 price objective on Colgate-Palmolive and gave the company a “hold” rating in a research report on Thursday, March 15th. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Jefferies Group reissued a “hold” rating and set a $79.00 price objective on shares of Colgate-Palmolive in a research report on Friday, January 26th. Finally, Stifel Nicolaus reissued a “hold” rating and set a $75.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, April 18th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $76.75.
Shares of Colgate-Palmolive opened at $62.25 on Tuesday, MarketBeat Ratings reports. Colgate-Palmolive has a 1-year low of $61.28 and a 1-year high of $77.91. The company has a quick ratio of 0.75, a current ratio of 1.08 and a debt-to-equity ratio of 64.85. The firm has a market cap of $54.28 billion, a PE ratio of 21.69, a P/E/G ratio of 2.46 and a beta of 0.75.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 27th. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The firm had revenue of $4 billion during the quarter, compared to the consensus estimate of $4.01 billion. During the same period last year, the company earned $0.67 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. sell-side analysts predict that Colgate-Palmolive will post 3.17 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th were issued a dividend of $0.42 per share. The ex-dividend date was Thursday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a dividend yield of 2.70%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.54%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
